Sergei Gryaznov
2023
In 2023, Sergei Gryaznov earned a total compensation of $894.7K as Chief Scientific Officer at MAIA Biotechnology, a 16% increase compared to previous year.
Compensation breakdown
| Option Awards | $477,415 |
|---|---|
| Salary | $363,000 |
| Other | $54,334 |
| Total | $894,749 |
Gryaznov received $477.4K in option awards, accounting for 53% of the total pay in 2023.
Gryaznov also received $363K in salary and $54.3K in other compensation.
Rankings
In 2023, Sergei Gryaznov's compensation ranked 1,338th out of 3,006 executives tracked by ExecPay. In other words, Gryaznov earned more than 55.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,338 out of 3,006 | 56th |
Division Manufacturing | 802 out of 1,650 | 51st |
Major group Chemicals And Allied Products | 532 out of 918 | 42nd |
Industry group Drugs | 519 out of 881 | 41st |
Industry Pharmaceutical Preparations | 360 out of 637 | 44th |
Source: SEC filing on April 16, 2024.
Gryaznov's colleagues
We found four more compensation records of executives who worked with Sergei Gryaznov at MAIA Biotechnology in 2023.